Vandana Batra Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Preclinical characterization of meta-[²¹¹At]astatobenzylguanidine ([²¹¹At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma   — Parallel 4 Novel Therapies and Immunotherapy